Treatment with five-fraction SBRT for prostate cancer may be more convenient than receiving traditional radiation therapy techniques, an expert said. For patients with low- to intermediate-risk ...

For men with the return of prostate cancer, a novel combined treatment can potentially give them an extended period before ...

A study led by UCLA Health Jonsson Comprehensive Cancer Center investigators found that stereotactic body radiotherapy (SBRT) ...

A phase 2 trial tested the efficacy of local stereotactic body radiation therapy (SBRT) use after radical prostatectomy.

For patients with intermediate-risk, localized prostate cancer, radiation therapy delivered in five sessions reduced ...

Researchers report longer progression-free survival when Lutetium-177 was combined with standard radiotherapy for limited ...

Physicians and scientists from the UCLA Health Jonsson Comprehensive Cancer Center will share the latest research and ...

Former President Joe Biden is now receiving radiation therapy for his prostate cancer, a spokesperson for the former ...

The phase 3 NRG Oncology GU005 trial tested SBRT vs MH-IMRT radiation for intermediate-risk prostate cancer for disease control and quality of life.

For patients with intermediate-risk localized prostate cancer, stereotactic body radiation therapy (SBRT) yields favorable bowel health-related quality of life (HRQOL).

A new clinical trial finds that people with a limited number of metastases from recurrent prostate cancer lived significantly ...

Patients with recurring prostate cancer who were treated with a new PSMA-targeted radioligand therapy before stereotactic ...